News
AVS Leverages Optimum Coverage of EUTELSAT 65 West A Satellite over Brazil to Expand Its Broadcast Services
Regulatory News:
AVS, a leading Brazilian service provider and integrator in the public and private sectors, has signed multiple contracts with Eutelsat Communications (Euronext Paris: ETL) for
Eutelsat and Thaicom to Partner for New Software-Defined Satellite over Asia
Regulatory News:
Eutelsat Communications (Euronext Paris: ETL) announces that its subsidiary Eutelsat Asia PTE. LTD. has signed a partnership agreement with Space Tech Innovation Limited (STI)
Teleperformance Launches a Share Buyback Program of up to €500 Million
Regulatory News:
Teleperformance (Paris:TEP), a global leader in digital business services, today announced it has decided to launch a share buyback program for a total amount of up to €500
ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANE) WITH A NOMINAL VALUE OF EUR 24,999,975.99
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
ABC arbitrage (ABCA): Initiation – A specialist arbitrage trader and asset manager
Eutelsat Communications: Full Year 2022-23 Results
Regulatory News:
The Board of Directors of Eutelsat Communications (ISIN: FR0010221234 / Euronext Paris: ETL), chaired by Dominique D’Hinnin, reviewed the financial results for the year ended 30
Kaufman & Broad SA: AVAILABILITY OF THE 2023 THE HALF YEARLY INTERIM FINANCIAL REPORT
Median Technologies: Financial Communication Schedule for the Second Half of 2023
Regulatory News:
Median Technologies (Euronext Growth - ALMDT) (Paris:ALMDT), announces the publication date for its 2023 half year results and its Q3, 2023 business performance:
Publicati
Axway Software (AXW.PA): Continued Strong Revenue Performance in H1 2023
Regulatory News:
Axway Software's Board of Directors, chaired by Pierre Pasquier, today approved the financial statements for the first half of 2023, which were subject to a limited review by
BILENDI: H1 2023 revenues: €29.6 million +2.0% at constant exchange rates
Prodware: Significant Increase in Revenue for H1 2023: €108.3M (+24.1%)
Successful entry into service of the multi-mission EUTELSAT 10B satellite
Regulatory News:
Eutelsat Communications (Euronext Paris: ETL) announces the successful entry into service of the multi-mission high-capacity EUTELSAT 10B satellite at the 10°East orbital
VERIMATRIX : Q2 2023 Revenue and H1 2023 Results
Regulatory News:
VERIMATRIX (Euronext Paris: VMX) has released its second-quarter revenue for 2023 and its financial results for H1-2023 to 30 June 2023.
"VERIMATRIX turned in a satisfactory
Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a “Strong Buy” Recommendation
Regulatory News:
Median Technologies (Euronext Growth - ALMDT) announces today the publication of an initiation report by Portzamparc Groupe BNP Paribas, a French leading group covering
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech
ROCTOOL: Confirmed acceleration in sales growth in first-half 2023: +24%
Little Cinema Digital erweitert den Einsatz von Verimatrix Streamkeeper und ist führend bei der Digitalisierung von Hollywood-Premieren
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass das in New York ansässige und für den Emmy nominierte
Little Cinema Digital Expands Use of Verimatrix Streamkeeper, Leads Ever-Expanding Digitization of Hollywood Premieres
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that New York-based and Emmy-Award nominated
Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe
Regulatory News:
Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech completes acquisition of Polyplus
Poxel Announces Upcoming Participation at the H.C. Wainwright 2nd Annual Kidney Conference
Regulatory News:
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic